Subscribe To
Apellis' (apls) earnings top, empaveli sales boost revenues
Apellis pharmaceuticals (APLS) reports better-than-expected results, beating both earnings and revenue ...
February 22, 2023, 3:03 pm
Ionis pharmaceuticals, inc. (ions) q4 2022 earnings call transcript
Ionis pharmaceuticals, Inc. (NASDAQ:IONS ) Q4 2022 Results Conference Call February 22, 2023 11:30 AM E...
February 22, 2023, 2:57 pm
Should you buy alnylam pharmaceuticals (alny) ahead of earnings?
Alnylam pharmaceuticals (ALNY) is seeing favorable earnings estimate revision activity and has a positi...
February 22, 2023, 12:03 pm
Ionis pharmaceuticals (ions) reports q4 loss, misses revenue estimates
Ionis pharmaceuticals (IONS) delivered earnings and revenue surprises of 65.09% and 3.82%, respectively...
February 22, 2023, 9:47 am
Analyst confidence in eli lilly boosted by product pipeline
Eli Lilly and Company (NYSE: LLY) is one of the most recognized names in the pharmaceutical industry. I...
February 22, 2023, 9:01 am
Spotlite360 iot solutions terminates agreement with e3 service group
SpotLite360 IOT Solutions (CSE:LITE) said it has terminated its agreement and relationship with E3 Service Group LLC, a facilities design and environ...
February 22, 2023, 8:05 am
Aytu biopharma to report second quarter fiscal 2023 financial results on february 21, 2023
ENGLEWOOD, CO / ACCESSWIRE / February 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage ...
February 21, 2023, 3:00 pm
Biocryst pharmaceuticals, inc. (bcrx) q4 2022 earnings call transcript
BioCryst pharmaceuticals, Inc. (NASDAQ:BCRX ) Q4 2022 Earnings Conference Call February 21, 2023 8:30 A...
February 21, 2023, 1:00 pm
Why biocryst pharmaceuticals stock is sinking today
Investors didn't like the drugmaker's Q4 update....
February 21, 2023, 11:55 am
Biocryst pharmaceuticals (bcrx) reports q4 loss, tops revenue estimates
BioCryst (BCRX) delivered earnings and revenue surprises of -100% and 6.11%, respectively, for the quarter ended December 2022. Do the numbers hold cl...
February 21, 2023, 9:47 am
Algernon pharmaceuticals says unit initiates traumatic brain injury research program with dmt; appoints global tbi expert as advisor
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Ne...
February 21, 2023, 9:09 am
89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutica...
February 21, 2023, 8:00 am
89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutica...
February 21, 2023, 8:00 am
89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutica...
February 21, 2023, 8:00 am
Should you invest in the vaneck pharmaceutical etf (pph)?
Sector ETF report for PPH...
February 21, 2023, 7:32 am
Altimmune to report fourth quarter and full year 2022 financial results and provide business update on february 28, 2023
GAITHERSBURG, Md., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharma...
February 21, 2023, 7:30 am
In8bio to present at the h.c. wainwright cell therapy virtual conference
NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical...
February 21, 2023, 7:00 am
Verona pharma to report fourth quarter and full year 2022 financial results and provide corporate update
LONDON and RALEIGH, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-st...
February 21, 2023, 2:00 am
Indivior sell-off ignores its solid long term potential, says leading broker
Indivior PLC (LSE:INDV)'s solid fundamentals have been overshadowed by market concerns about a $290m legal provision, according to Jefferies. Despite ...
February 20, 2023, 12:16 pm
3 dirt-cheap stocks to buy sooner rather than later
These pharmaceutical stocks probably won't stay so attractively valued for too much longer....
February 18, 2023, 8:14 am